Evidence map›Paper›PMID 36835957›Full record

ArticleJournal of clinical medicine2023

Sustained Myocarditis following Messenger RNA Vaccination against Coronavirus Disease 2019: Relation to Neutralizing Antibody and Amelioration by Low-Dose Booster Vaccination.

Koji Miyazaki, Toshiharu Fujii, Kikue Mori, Ryuichi Tamimoto, Hirofumi Nagamatsu, Tsutomu Murakami, Yasunori Cho, Shinya Goto, Hidezo Mori

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Koji MiyazakiDepartment of General Internal Medicine, Tokai University Hachioji Hospital, 1838 Ishikawacho, Hachioji, Tokyo 192-0032, Japan.
Toshiharu FujiiShoju Sagamihara Clinic, 820-1-101 Harataima, Sagamihara 252-0336, Japan.ORCID 0000-0002-0011-3051
Kikue MoriDepartment of Nutritional Science, Faculty of Applied Bioscience, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo 156-8502, Japan.ORCID 0000-0003-4429-420X
Ryuichi TamimotoDepartment of Cardiovascular Surgery, Tokai University School of Medicine, 143 Simokasuya, Isehara 259-1193, Japan.
Hirofumi NagamatsuShoju Sagamihara Clinic, 820-1-101 Harataima, Sagamihara 252-0336, Japan.ORCID 0000-0001-6398-4869
Tsutomu MurakamiShoju Sagamihara Clinic, 820-1-101 Harataima, Sagamihara 252-0336, Japan.
Yasunori ChoDepartment of Cardiovascular Surgery, Tokai University School of Medicine, 143 Simokasuya, Isehara 259-1193, Japan.
Shinya GotoDepartment of Cardiovascular Medicine, Tokai University School of Medicine, 143 Simokasuya, Isehara 259-1193, Japan.
Hidezo MoriShoju Sagamihara Clinic, 820-1-101 Harataima, Sagamihara 252-0336, Japan.
Tokai University · JPTokai University Hachioji Hospital · JPTokyo University of Agriculture · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We recently reported that sub-acute myocarditis occurred following the initial two doses of messenger RNA-based vaccination against coronavirus disease 2019 (0.3 mL Comirnaty

Indexed as

coronavirus disease 2019 (COVID-19)heart failuremyocarditisneutralizing antibodyvaccine

Identifiers

PMID36835957
PMCPMC9961568
OpenAlexW4320496111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.